“No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort” (2020) Italian Journal of Medicine, 14(3), pp. 162–166. doi:10.4081/itjm.2020.1313.